Millennium Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.39M | Buy |
285,174
+70,508
| +33% | +$741K | ﹤0.01% | 3704 |
|
|
2025
Q4 | $3.09M | Buy |
214,666
+128,007
| +148% | +$1.6M | ﹤0.01% | 3521 |
|
|
2025
Q3 | $836K | Sell |
86,659
-25,290
| -23% | -$224K | ﹤0.01% | 4754 |
|
|
2025
Q2 | $919K | Sell |
111,949
-220,880
| -66% | -$1.85M | ﹤0.01% | 4470 |
|
|
2025
Q1 | $2.38M | Sell |
332,829
-989,515
| -75% | -$7.36M | ﹤0.01% | 3615 |
|
|
2024
Q4 | $10.2M | Buy |
1,322,344
+1,061,187
| +406% | +$9.96M | 0.01% | 2159 |
|
|
2024
Q3 | $2.74M | Sell |
261,157
-45,330
| -15% | -$553K | ﹤0.01% | 3406 |
|
|
2024
Q2 | $3.59M | Buy |
306,487
+140,666
| +85% | +$2.19M | ﹤0.01% | 3031 |
|
|
2024
Q1 | $3.49M | Buy |
165,821
+110,498
| +200% | +$1.97M | ﹤0.01% | 3241 |
|
|
2023
Q4 | $993K | Sell |
55,323
-146,399
| -73% | -$2.58M | ﹤0.01% | 4171 |
|
|
2023
Q3 | $3.32M | Sell |
201,722
-2,621
| -1% | -$47.5K | ﹤0.01% | 3101 |
|
|
2023
Q2 | $4.08M | Sell |
204,343
-514,868
| -72% | -$9.92M | ﹤0.01% | 2846 |
|
|
2023
Q1 | $13.6M | Buy |
719,211
+697,379
| +3,194% | +$15.4M | 0.01% | 1672 |
|
|
2022
Q4 | $495K | Buy |
21,832
+4,789
| +28% | +$108K | ﹤0.01% | 4752 |
|
|
2022
Q3 | $450K | Buy |
+17,043
| New | +$506K | ﹤0.01% | 5052 |
|
|
2022
Q2 | – | Sell |
-218,316
| Closed | -$7.25M | – | 7416 |
|
|
2022
Q1 | $7.25M | Buy |
218,316
+189,703
| +663% | +$5.27M | ﹤0.01% | 2526 |
|
|
2021
Q4 | $936K | Buy |
28,613
+22,441
| +364% | +$764K | ﹤0.01% | 4467 |
|
|
2021
Q3 | $259K | Sell |
6,172
-188,955
| -97% | -$6.8M | ﹤0.01% | 5921 |
|
|
2021
Q2 | $7.58M | Sell |
195,127
-17,294
| -8% | -$619K | ﹤0.01% | 2237 |
|
|
2021
Q1 | $7.25M | Buy |
212,421
+197,735
| +1,346% | +$8.43M | 0.01% | 2154 |
|
|
2020
Q4 | $666K | Buy |
14,686
+716
| +5% | +$25K | ﹤0.01% | 3990 |
|
|
2020
Q3 | $384 | Sell |
13,970
-140,374
| -91% | -$4.58M | ﹤0.01% | 3711 |
|
|
2020
Q2 | $5.68M | Buy |
+154,344
| New | +$5.75M | 0.01% | 1643 |
|
|
2020
Q1 | – | Sell |
-105,496
| Closed | -$4.32M | – | 4366 |
|
|
2019
Q4 | $4.32M | Buy |
+105,496
| New | +$4.17M | 0.01% | 2049 |
|
|
2018
Q4 | – | Sell |
-130,238
| Closed | -$9.83M | – | 4106 |
|
|
2018
Q3 | $9.83M | Buy |
130,238
+116,336
| +837% | +$8.38M | 0.01% | 1339 |
|
|
2018
Q2 | $997K | Sell |
13,902
-216,935
| -94% | -$10.4M | ﹤0.01% | 2839 |
|
|
2018
Q1 | $6.89M | Buy |
230,837
+134,479
| +140% | +$3.91M | 0.01% | 1598 |
|
|
2017
Q4 | $3.2M | Buy |
+96,358
| New | +$2.9M | ﹤0.01% | 1991 |
|
|
2017
Q3 | – | Sell |
-320,247
| Closed | -$7.21M | – | 3810 |
|
|
2017
Q2 | $6.33M | Sell |
320,247
-421,990
| -57% | -$8.17M | 0.01% | 1347 |
|
|
2017
Q1 | $14.3M | Buy |
742,237
+282,123
| +61% | +$5.44M | 0.03% | 831 |
|
|
2016
Q4 | $8.54M | Sell |
460,114
-13,738
| -3% | -$263K | 0.02% | 1017 |
|
|
2016
Q3 | $6.64M | Buy |
473,852
+411,059
| +655% | +$4.54M | 0.01% | 1163 |
|
|
2016
Q2 | $502K | Buy |
62,793
+46,961
| +297% | +$521K | ﹤0.01% | 2489 |
|
|
2016
Q1 | $171K | Sell |
15,832
-61,243
| -79% | -$784K | ﹤0.01% | 2993 |
|
|
2015
Q4 | $1.28M | Buy |
77,075
+20,772
| +37% | +$412K | ﹤0.01% | 2179 |
|
|
2015
Q3 | $1.24M | Buy |
+56,303
| New | +$1.44M | ﹤0.01% | 2173 |
|
Other funds holding RGNX
RG
VCM
IHAM
Millennium Management's RGNX Position: Q1 2026 in Review
Millennium Management increased its Regenxbio (RGNX) stake by 33% in Q1 2026, buying an estimated $741K and bringing the position to 285,174 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #3704.
Millennium Management first reported a position in RGNX in Q3 2015 and has held it in 36 quarters since. The position peaked at $14.3M in Q1 2017. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.
- Millennium Management held 285,174 shares of Regenxbio worth $2.39M as of Q1 2026.
- Millennium Management bought 70,508 Regenxbio shares in Q1 2026, an estimated $741K.
- Regenxbio made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3704 holding.
- Millennium Management first reported a position in Regenxbio in Q3 2015 and has held it in 36 quarters since.
- Millennium Management's Regenxbio position peaked at $14.3M in Q1 2017.
- 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.